Published in Arch Dermatol Res on January 01, 1989
Type I interferon: potential therapeutic target for psoriasis? PLoS One (2008) 2.08
Function and regulation of retinoic acid-inducible gene-I. Crit Rev Immunol (2010) 1.15
Constitutive expression of alpha interferon by skin dendritic cells confers resistance to infection by foot-and-mouth disease virus. J Virol (2005) 0.95
Prostaglandins modulate macrophage Ia expression. Nature (1982) 3.83
Role of interferon-gamma in cutaneous trafficking of lymphocytes with emphasis on molecular and cellular adhesion events. Arch Dermatol (1988) 1.65
Inducible expression of class II major histocompatibility complex antigens and the immunogenicity of vascular endothelium. Transplantation (1986) 1.64
Opposing effects of glucocorticoids on interferon-gamma-induced murine macrophage Fc receptor and Ia antigen expression. J Immunol (1985) 1.30
HLA-DR expression on keratinocytes is a common feature of diseased skin. Br J Dermatol (1986) 1.24
Modulation of Ia-like antigen expression and antigen-presenting activity of human monocytes by endotoxin and zymosan A. J Immunol (1981) 1.20
Alpha-fetoprotein inhibits macrophage expression of Ia antigens. J Immunol (1984) 1.19
Interferon in suction blister fluid from psoriatic lesions. Br J Dermatol (1983) 1.17
Multiple sclerosis: involvement of interferons in lesion pathogenesis. Ann Neurol (1988) 1.16
Immune complex effects on murine macrophages. I. Immune complexes suppress interferon-gamma induction of Ia expression. J Immunol (1985) 1.13
Ia-like antigens in lichen planus. Acta Derm Venereol (1980) 1.12
Induction of macrophage Ia antigen expression by rIFN-gamma and down-regulation by IFN-alpha/beta and dexamethasone are regulated transcriptionally. J Immunol (1988) 1.07
Effect of serotonin on murine macrophages: suppression of Ia expression by serotonin and its reversal by 5-HT2 serotonergic receptor antagonists. J Immunol (1986) 1.06
HLA-DR antigen expression on keratinocytes in highly inflamed parts of psoriatic lesions. Br J Dermatol (1987) 1.03
Human interferon-gamma induces expression of HLA-DR on keratinocytes and melanocytes. Arch Dermatol Res (1985) 0.99
Regulation of HLA class II antigen expression: intracellular signaling molecules responsible for the regulation by IFN-gamma and cross-linking of Fc receptors in HL-60 cells. J Immunol (1987) 0.95
Virus replication and induction of interferon in human epidermal keratinocytes following infection with herpes simplex virus. J Invest Dermatol (1984) 0.95
Immune interferon: a pleiotropic lymphokine with multiple effects. Immunol Today (1985) 0.94
Normal human epidermis contains an interferon-like protein. J Cell Biol (1986) 0.92
Psoriasis and alpha-interferon. Lancet (1986) 0.90
Quantitation of dendritic cells in normal and abnormal human epidermis using monoclonal antibodies directed against Ia and HTA antigens. J Invest Dermatol (1983) 0.90
Fc gamma-receptors and HLA-DR antigens on endothelial cells in psoriatic skin lesions. Acta Derm Venereol (1988) 0.89
Cellular localization of alpha-interferon in hepatitis B virus-infected liver tissue. Hepatology (1986) 0.89
Anti-Ia-reactive cells in mycosis fungoides: a study of skin biopsies, single epidermal cells and circulating T lymphocytes. Acta Derm Venereol (1981) 0.87
Interferon review. Invest Radiol (1987) 0.86
Fc gamma receptors on keratinocytes in psoriasis. Arch Dermatol Res (1988) 0.85
Interferon inhibits the growth of Legionella micdadei in mouse L cells. J Interferon Res (1986) 0.83
Demonstration of Ia-like antigens on T lymphocytes in lesions of psoriasis, lichen planus and discoid lupus erythematosus. Acta Derm Venereol (1983) 0.80
Decreased production of interferon in whole blood cultures derived from patients with psoriasis. J Invest Dermatol (1988) 0.79
Interferons and psoriasis--1987 perspective. Dermatologica (1987) 0.77
Increased affiliative response to vasopressin in mice expressing the V1a receptor from a monogamous vole. Nature (1999) 2.03
The role of nerve biopsies in the diagnosis and management of leprosy. Lepr Rev (1989) 1.53
Tribal differences in perception of tuberculosis: a possible role in tuberculosis control in Arusha, Tanzania. Int J Tuberc Lung Dis (2003) 1.51
Complement-regulatory proteins in ovarian malignancies. Int J Cancer (1997) 1.44
Human microglial cells have phenotypic and functional characteristics in common with both macrophages and dendritic antigen-presenting cells. J Leukoc Biol (1994) 1.44
RFX-B is the gene responsible for the most common cause of the bare lymphocyte syndrome, an MHC class II immunodeficiency. Immunity (1999) 1.39
Species differences in V1a receptor gene expression in monogamous and nonmonogamous voles: behavioral consequences. Behav Neurosci (1997) 1.32
Mycobacterial adenitis: role of Mycobacterium bovis, non-tuberculous mycobacteria, HIV infection, and risk factors in Arusha, Tanzania. East Afr Med J (2004) 1.27
The Swedish snus and the Sudanese toombak: are they different? Oral Oncol (1998) 1.22
Interferon in suction blister fluid from psoriatic lesions. Br J Dermatol (1983) 1.17
A mouse model for slowly progressive primary tuberculosis. Scand J Immunol (1999) 1.16
Pathogenic isolates in meningitis patients in Dar Es Salaam, Tanzania. East Afr Med J (2001) 1.10
Complement receptors in human renal glomeruli. Scand J Immunol (1976) 1.09
Toombak use and cigarette smoking in the Sudan: estimates of prevalence in the Nile state. Prev Med (1998) 1.09
Reactive microglia in multiple sclerosis lesions have an increased expression of receptors for the Fc part of IgG. J Neurol Sci (1994) 1.06
Species differences in central oxytocin receptor gene expression: comparative analysis of promoter sequences. J Neuroendocrinol (1996) 1.05
Characterization of mononuclear cell infiltrates in psoriatic lesions. J Invest Dermatol (1978) 1.04
Isolation and characterization of Fc gamma receptors from human placenta. Acta Pathol Microbiol Scand C (1981) 1.04
Isolation of Mycoplasma hominis from cerebrospinal fluid. Scand J Infect Dis (1973) 1.02
IgG subclass antibodies to serogroup B meningococcal outer membrane antigens following infection and vaccination. APMIS (1990) 1.01
Increased expression of fas ligand in human tuberculosis and leprosy lesions: a potential novel mechanism of immune evasion in mycobacterial infection. Scand J Immunol (2001) 1.01
Subpopulations of mononuclear cells in lesions of psoriasis, lichen planus and discoid lupus erythematosus studied using monoclonal antibodies. Acta Derm Venereol (1982) 1.00
Expression and function of CD59 on colonic adenocarcinoma cells. Eur J Immunol (1994) 1.00
Comparison of parasitological and immunological methods in the diagnosis of leishmaniasis in Ethiopia. Trans R Soc Trop Med Hyg (1992) 0.98
Associated disorders in myasthenia gravis: autoimmune diseases and their relation to thymectomy. Acta Neurol Scand (1989) 0.98
In situ identification of mononuclear cells in cutaneous infiltrates in discoid lupus erythematosus, sarcoidosis and secondary syphilis. Acta Derm Venereol (1981) 0.98
The role of livestock keeping in tuberculosis trends in Arusha, Tanzania. Int J Tuberc Lung Dis (2003) 0.97
Rabbit antiserum to a citric acid extract of human skeletal muscle staining thymomas from myasthenia gravis patients. J Neuroimmunol (1984) 0.96
Characterisation of the complement-regulatory proteins decay-accelerating factor (DAF, CD55) and membrane cofactor protein (MCP, CD46) on a human colonic adenocarcinoma cell line. Cancer Immunol Immunother (1996) 0.96
Fc receptors in human placenta. Scand J Immunol (1975) 0.96
A mouse model for latent tuberculosis. Scand J Infect Dis (1998) 0.96
A monoclonal antibody inhibiting human placental Fc gamma-receptor activity. Int Arch Allergy Appl Immunol (1984) 0.95
The expression of CD59 in normal human nervous tissue. Immunology (1994) 0.95
Co-localization of the neonatal Fc gamma receptor and IgG in human placental term syncytiotrophoblasts. Eur J Immunol (1996) 0.94
Increased Bcl-2 and reduced Bax expression in infected macrophages in slowly progressive primary murine Mycobacterium tuberculosis infection. Scand J Immunol (2002) 0.93
Soluble CD59 in pregnancy and infancy. Immunol Lett (1993) 0.93
Increased expression of Fas ligand on Mycobacterium tuberculosis infected macrophages: a potential novel mechanism of immune evasion by Mycobacterium tuberculosis? Inflammation (1999) 0.92
In-situ characterization of mononuclear cell infiltrates in lesions of multiple sclerosis. Neuropathol Appl Neurobiol (1983) 0.92
Acquired angioedema and hypocompleentemia in a patient with myelofibrosis. Effect of danazol treatment. Acta Med Scand (1980) 0.92
Benign cementoblastoma. Int J Oral Surg (1979) 0.92
In situ characterization of mononuclear cells in human dental periapical inflammatory lesions using monoclonal antibodies. Oral Surg Oral Med Oral Pathol (1984) 0.92
Serum opsonins to serogroup B meningococci in meningococcal disease. Scand J Infect Dis (1989) 0.92
Multiple FC receptors in the human placenta. Acta Pathol Microbiol Scand C (1977) 0.92
In situ characterization of the foam cells in early human atherosclerotic lesions. Acta Pathol Microbiol Immunol Scand C (1984) 0.91
Fc receptor for IgG (FcR) on rat microglia. J Neuroimmunol (1994) 0.91
Fc receptors for IgG on cultured human microglia mediate cytotoxicity and phagocytosis of antibody-coated targets. J Neuropathol Exp Neurol (1994) 0.91
Patterns of cell death induced by eluates from denture base acrylic resins in U-937 human monoblastoid cells. Eur J Oral Sci (2000) 0.90
The placental Fcgamma receptors studied using immune complexes of peroxidase. Scand J Immunol (1978) 0.90
Comparative detection frequency of 6 putative periodontal pathogens in Sudanese and Norwegian adult periodontitis patients. J Periodontol (1994) 0.90
Fc gamma-receptors and HLA-DR antigens on endothelial cells in psoriatic skin lesions. Acta Derm Venereol (1988) 0.89
Carbamazepine effects on mononuclear blood cells in epileptic patients. Acta Neurol Scand (1986) 0.89
Characterization of mononuclear cells in sarcoid skin lesions using monoclonal antibodies. Acta Pathol Microbiol Immunol Scand C (1983) 0.89
Fc gamma receptor heterogeneity in the human placenta. Scand J Immunol (1990) 0.89
Similarities of Fcgamma receptors on trophoblasts and placental endothelial cells. Scand J Immunol (1977) 0.89
Patient knowledge, practices and challenges to health care system in early diagnosis of mycobacterial adenitis. East Afr Med J (2005) 0.88
Prevalence of, and risk factors for, HSV-2 antibodies in sexually transmitted disease patients, healthy pregnant females, blood donors and medical students in Tanzania and Norway. Epidemiol Infect (2005) 0.88
Lymphocyte subpopulations and lymphocyte function in phenytoin-treated patients with epilepsy. Int J Immunopharmacol (1982) 0.88
A double-blind comparison of acitretin and etretinate in the treatment of severe psoriasis. Results of a Nordic multicentre study. Acta Derm Venereol (1989) 0.87
Levels and avidity of antibodies to tetanus toxoid in children aged 1-15 years in Dar es Salaam and Bagamoyo, Tanzania. Ann Trop Paediatr (2000) 0.86
Localization of Fc gamma receptors in the human central nervous system. Acta Pathol Microbiol Immunol Scand C (1982) 0.86
In situ expression of cytokines and cellular phenotypes in the lungs of mice with slowly progressive primary tuberculosis. Scand J Immunol (2000) 0.86
Antibodies to peripheral nerve tissue in sera from patients with acute Guillain-Barré syndrome demonstrated by a mixed haemagglutination technique. J Neuroimmunol (1982) 0.86
Stage-related correlations between immunoglobulins and complement components in preoperative sera from patients with gastric carcinoma. Eur J Cancer Clin Oncol (1983) 0.86
Clobetasol propionate followed by calcipotriol is superior to calcipotriol alone in topical treatment of psoriasis. J Eur Acad Dermatol Venereol (1998) 0.85
Ryanodine receptor antibodies related to severity of thymoma associated myasthenia gravis. J Neurol Neurosurg Psychiatry (1994) 0.85
Pre-operative [correction of Properative] psychological variables predict immunological status in patients with operable breast cancer. Psychooncology (1997) 0.85
Expression of keratin 13, 14 and 19 in oral squamous cell carcinomas from Sudanese snuff dippers: lack of association with human papillomavirus infection. APMIS (1998) 0.85
Once daily treatment of psoriasis with tacalcitol compared with twice daily treatment with calcipotriol. A double-blind trial. Br J Dermatol (1997) 0.85
The 5' flanking region of the monogamous prairie vole oxytocin receptor gene directs tissue-specific expression in transgenic mice. Ann N Y Acad Sci (1997) 0.85
Immunity to tetanus in male adults in Dar es Salaam, Tanzania. East Afr Med J (2002) 0.84
Complement receptors in human peripheral nerve tissue. Acta Pathol Microbiol Scand C (1979) 0.84
The effect of Goeckerman therapy on interferon in serum and suction blister fluid from patients with psoriasis. Br J Dermatol (1986) 0.84
Complement receptors in pathological human renal glomeruli. Scand J Immunol (1978) 0.84
Antibodies in human sera to rabbit erythrocytes. Immunology (1967) 0.84
Lymphocyte subpopulations in thymus and blood from patients with myasthenia gravis. J Neurol Neurosurg Psychiatry (1979) 0.84
Properties of the solubilized placental receptor for IgG. Int Arch Allergy Appl Immunol (1982) 0.84
IgG Fc receptor heterogeneity in human peripheral nerves. Acta Neurol Scand (1991) 0.83
Enzyme histochemistry of induced heterotropic bone formation in guinea-pigs. Arch Oral Biol (1979) 0.83
The pathogenesis of Leishmania aethiopica infection in BALB/c mice. Scand J Immunol (1990) 0.83
Surface markers in non-phagocytic hairy cell leukemia. Acta Pathol Microbiol Scand C (1977) 0.83
The influence of tumour necrosis factor-alpha, interleukin-1 beta and interferon-gamma on the expression and function of the complement regulatory protein CD59 on the human colonic adenocarcinoma cell line HT29. Scand J Immunol (1995) 0.83
Traffic of T and B lymphocytes in the normal spleen. Scand J Haematol (1978) 0.83
Properties of Fcgamma receptors in normal and malignant human tissues. Scand J Immunol (1976) 0.83
Resistance of ovarian teratocarcinoma cell spheroids to complement-mediated lysis. Br J Cancer (1997) 0.82
IgG Fc receptors in sera from patients with rheumatoid arthritis and systemic lupus erythematosus. Scand J Rheumatol Suppl (1988) 0.82
In situ characterization of mononuclear cells in human chronic marginal periodontitis using monoclonal antibodies. J Periodontal Res (1986) 0.82
Myasthenia gravis: difference between thymoma-associated antibodies and cross-striational skeletal muscle antibodies. Neurology (1984) 0.82
Systems biology of the neurospora biological clock. IET Syst Biol (2007) 0.82
In vitro effect of ethanol on subpopulations of human blood mononuclear cells. Int Arch Allergy Appl Immunol (1982) 0.81
Factors mediating the binding of immune complexes to cryostat sections of psoriatic lesions. Int Arch Allergy Appl Immunol (1982) 0.81
Co-localization of beta 2-microglobulin and IgG in human placental syncytiotrophoblasts. Eur J Immunol (1996) 0.81
Ryanodine receptor autoantibodies in myasthenia gravis patients with a thymoma. Ann Neurol (1992) 0.81